Inactive Instrument
Entia Biosciences, Inc. Stock Other OTC
Stocks
ERGO
US29384E1047
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 235K 205K 191K 175K 331K 22.44M 336K 2.25M 882K 11.19M 884K 865K 36.91M | P/E 2015 |
-0.97x | P/E 2016 | -1.13x |
|---|---|---|---|---|---|
| Enterprise Value | 1.21M 1.05M 978K 898K 1.69M 115M 1.72M 11.53M 4.52M 57.3M 4.53M 4.43M 189M | EV / Sales 2015 |
8.29x | EV / Sales 2016 | 9.59x |
| Free-Float |
99.44% | Yield 2015 * |
-
| Yield 2016 | - |
| 1 day | -28.00% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 69 | 2017-11-27 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -28.00% | -1.10% | - | - | 6.81K | |
| -0.36% | +0.14% | -2.06% | +14.33% | 48.22B | |
| -2.71% | -2.99% | +398.09% | +472.12% | 38.79B | |
| -0.71% | +9.45% | +27.90% | +7.89% | 38.41B | |
| -0.71% | -3.72% | +4.94% | +52.45% | 34.88B | |
| -2.41% | +1.96% | +11.68% | +38.17% | 29.19B | |
| -0.66% | -2.73% | +35.50% | +122.17% | 16B | |
| -0.19% | -3.93% | - | - | 16.05B | |
| -0.62% | +1.23% | +2.76% | +15.05% | 13.53B | |
| -3.15% | -6.14% | -4.82% | -36.90% | 12.22B | |
| Average | -3.95% | -0.66% | +59.25% | +85.66% | 27.48B | |
| Weighted average by Cap. | -1.23% | +0.15% | +75.56% | +103.60% |
| 2015 | 2016 | |
|---|---|---|
| Net sales | 347K 301K 281K 258K 487K 33.07M 496K 3.32M 1.3M 16.49M 1.3M 1.27M 54.39M | 265K 231K 215K 198K 373K 25.3M 379K 2.54M 995K 12.62M 997K 975K 41.62M |
| Net income | -2.26M -1.96M -1.83M -1.68M -3.17M -215M -3.23M -21.62M -8.47M -107M -8.49M -8.3M -354M | -1.4M -1.21M -1.13M -1.04M -1.96M -133M -1.99M -13.35M -5.23M -66.35M -5.24M -5.13M -219M |
| Net Debt | 255K 222K 207K 190K 358K 24.32M 365K 2.44M 956K 12.13M 958K 937K 39.99M | 970K 843K 787K 722K 1.36M 92.45M 1.39M 9.28M 3.63M 46.1M 3.64M 3.56M 152M |
Employees
-
